GeneMatrix Inc. (KOSDAQ:109820)
South Korea · Delayed Price · Currency is KRW 1,595.00
+7.00 (0.44%)
At close: Sep 17, 2026
GeneMatrix Market Cap
GeneMatrix has a market cap or net worth of 32.53 billion as of September 17, 2026. Its market cap has decreased by -35.03% in one year.
Market Cap
32.53B
Enterprise Value
n/a
Revenue
4.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,595.00
ChartMarket Cap Chart
Since November 6, 2009, GeneMatrix's market cap has decreased from 33.85B to 32.53B, a decrease of -3.90%. That is a compound annual growth rate of -0.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 32.53B | -35.03% |
| Dec 30, 2025 | 50.07B | -9.74% |
| Dec 30, 2024 | 55.47B | -12.40% |
| Dec 28, 2023 | 63.32B | -23.43% |
| Dec 29, 2022 | 82.69B | -58.54% |
| Dec 30, 2021 | 199.45B | -62.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 231.31B |
| 3billion | 129.20B |
| Inventera | 82.59B |
| GENINUS | 76.34B |
| GC Medical Science | 73.45B |
| Cytogen | 68.69B |
| Protia | 66.97B |
| HLB Panagene | 52.90B |